يعرض 1,761 - 1,780 نتائج من 13,123 نتيجة بحث عن '(( significant ((side decrease) OR (step decrease)) ) OR ( significantly increased decrease ))', وقت الاستعلام: 0.52s تنقيح النتائج
  1. 1761
  2. 1762
  3. 1763
  4. 1764

    Presentation 1_Decreased brain-derived neurotrophic factor expression in chronic kidney disease: integrated clinical and experimental evidence.pptx حسب Juan Chen (61123)

    منشور في 2025
    "…</p>Conclusion<p>This study integrated meta-analysis, murine model validation, and single-cell transcriptomic profiling to demonstrate a significant reduction of BDNF in CKD. Furthermore, renal BDNF expression decreased locally, predominantly originating from proximal tubule cells, macrophages, and podocytes, possibly epigenetically inhibited by the upregulation of lnc RNA Bdnf-as.…"
  5. 1765
  6. 1766
  7. 1767
  8. 1768
  9. 1769
  10. 1770
  11. 1771

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  12. 1772

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  13. 1773

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf حسب Mi-Ae Lyu (20413646)

    منشور في 2025
    "…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …"
  14. 1774

    Bar charts showing the numbers of significantly differentially expressed genes for the different contrasts. حسب Gillian P. McHugo (8965919)

    منشور في 2025
    "…</sub> ≤ 0.05) with increased and decreased expression, respectively. The position on the horizontal indicates the number of days post-infection (dpi) and the colour of the bars represents the tissue. …"
  15. 1775

    RT-qPCR Primer. حسب Dequan Wang (6007007)

    منشور في 2024
    الموضوعات:
  16. 1776

    CCND1 is a target gene of miR-1247-3p. حسب Dequan Wang (6007007)

    منشور في 2024
    الموضوعات:
  17. 1777
  18. 1778

    miR-1247-3p plasmid. حسب Dequan Wang (6007007)

    منشور في 2024
    الموضوعات:
  19. 1779
  20. 1780

    Dual luciferase primer. حسب Dequan Wang (6007007)

    منشور في 2024
    الموضوعات: